Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

European Innovation Council · Running

GO-Pen The first universal and price-neutral insulin pen

Coordinator
Go-Pen Aps, Denmark
Runs
1 March 2023 to 31 August 2025
Status
Running
EU funding
€2.5m
Total cost
€4.6m
Partners
1 organisations in 1 countries
Type
European Innovation Council
Grant agreement
190178477

What the project is doing

In the project's own words, from its summary on CORDIS.

The challenge for many people with diabetes (PwD) is that they dont get the right dose of insulin at the right time. This can potentially give long term health issues, and even shorten their lifetime. Today, this is an everyday challenge for more than 13 million people that still inject insulin with a 100 years old outdated technology (syringes and needles) and cannot afford branded insulin and modern pens. GO-Pen ApS developed the 1st affordable, safe, and sustainable insulin injection system that fits the unmet health needs in the worlds most resource constrained population.

The UNIPEN system innovation relies on the possibility of refilling a disposable cartridge with any kind of insulin available, resulting in a cost-competitive device to syringes solution improving the accuracy. Now, with the support of the EIC-A funding, we intend to refine the design of the UNIPEN device, demonstrate its design and clinical usability, and fine-tune the scale-up production.

Topics

Who is involved

OrganisationCityCountryRole
Go-Pen ApsKongens LyngbyDenmarkCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI